About Akesiss
Akesiss is a Healthcare company based in Kochi (India). It operates as a pharmaceutical manufacturing and marketing of affordable medicines in the healthcare sector. The company has 251 employees. Its Indian entity Akesiss Pharma Private Limited reported revenue of ₹72.51 Cr. Akesiss offers products and services including Medicines and Therapeutics. Its focus areas include Pharmaceuticals, Drug Manufacturing, Therapeutics and Manufacturing.
Company details
Akesiss Pharma is recognized as a pharmaceutical entity that operates across the product value chain, from formulation development to marketing, with divisions focused on therapeutic segments like Cardiology and Endocrinology. Its mission is seen as improving patient quality of life through the provision of innovative, affordable healthcare products that meet international standards. A motivated team is maintained through training and development, while testimonials highlight the delivery of high-quality medicines at accessible prices to reduce suffering globally. Expansion into new segments is pursued to benefit patients and partners.
- Headquarters Kochi, India
- Employees 251
- SectorsHealthcare
- Email••••••••
- Social LinkedIn
- Legal Name Akesiss Pharma Private Limited
- Date of Incorporation 18 Nov, 2008
- Jurisdiction Kochi, Kerala, India
- Annual Revenue₹72.51 Cr
FY 2025 · +22% YoY
- Net Profit₹6.70 Cr
FY 2025 · 9% margin
- EBITDA₹10.92 Cr
FY 2025 · 15% margin
- Employee Count251
Associated legal entities of Akesiss
Akesiss operates through Akesiss Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Akesiss Pharma Private Limited CIN U24232KL2008PTC023419 | Active | 18 Nov 2008 | Kochi, Kerala | ₹72.5 Cr | 251 | 5 | View details |
Products & Services of Akesiss
Akesiss offers a comprehensive portfolio of products and services, including Medicines and Therapeutics.
High-quality medicines are manufactured and marketed for various health conditions across therapeutic segments.
Innovative therapeutic products are developed and distributed for specialties like Cardiology and Endocrinology.
Board of directors of Akesiss Pharma Private Limited (Akesiss)
Akesiss Pharma Private Limited is the primary company behind Akesiss. The board of Akesiss Pharma Private Limited currently have 5 directors; the longest-serving is Sharatkumar Kumarakurup, appointed in 2008. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sharatkumar Kumarakurup DIN 02366721 | Whole-time director | 18 Nov 2008 | 17 yrs 11 mo | Akesiss Pharma Private Limited |
| Padmadas Panjajanyam DIN 02358309 | Whole-time director | 18 Nov 2008 | 17 yrs 11 mo | Akesiss Pharma Private Limited |
| Ashok Kumar Kannampalam DIN 02358270 | Managing Director | 18 Nov 2008 | 17 yrs 11 mo | Akesiss Pharma Private Limited |
| Thomsan George DIN 02358354 | Whole-time director | 18 Nov 2008 | 17 yrs 11 mo | Akesiss Pharma Private Limited |
| Narayan Biji DIN 06447225 | Director | 01 Jan 2013 | 13 yrs 9 mo | Akesiss Pharma Private Limited |
Financials of Akesiss
Figures of Akesiss Pharma Private Limited, the primary company behind Akesiss, for FY 2025. Revenue was ₹72.51 Cr (+22% year on year). Net profit was ₹6.70 Cr (9% margin). EBITDA was ₹10.92 Cr (15% margin). Revenue has grown at a compounded annual rate of +11% over three years and +9% over five years.
- ₹72.51 CrRevenue · FY 2025 · +22% YoY
- ₹6.70 CrNet profit · 9% margin
- ₹10.92 CrEBITDA · 15% margin
- ₹45 LakhPaid-up capital
- 251Employees (provident fund records)
- +11%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Akesiss Pharma Private Limited are on its company page.
Detailed financial statements for Akesiss
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Akesiss (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Akesiss
Akesiss is headquartered in Kochi, India. It is registered at Kochi, Kerala, India.
Akesiss has 251 employees.
The primary company behind Akesiss, Akesiss Pharma Private Limited, reported revenue of ₹72.51 Cr for FY 2025, up 22% year on year.
Akesiss Pharma is recognized as a pharmaceutical entity that operates across the product value chain, from formulation development to marketing, with divisions focused on therapeutic segments like Cardiology and Endocrinology. Its mission is seen as improving patient quality of life through the provision of innovative, affordable healthcare products that meet international standards. A motivated team is maintained through training and development, while testimonials highlight the delivery of high-quality medicines at accessible prices to reduce suffering globally. Expansion into new segments is pursued to benefit patients and partners.
Akesiss offers Medicines and Therapeutics.
Akesiss operates through Akesiss Pharma Private Limited.
The legal entities of Akesiss currently have 5 directors, including Sharatkumar Kumarakurup, Padmadas Panjajanyam, Ashok Kumar Kannampalam and others.